Test Price
2,800 AED✅ Home Collection Available
TIMM8A Gene Jensen Syndrome Genetic Test in UAE | 2800 AED | DHA Guidelines
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation included.
- Insurance: Direct Billing Verification — WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TIMM8A gene test utilises Next‑Generation Sequencing to detect pathogenic variants causing Jensen syndrome (Mohr‑Tranebjaerg syndrome), a rare X‑linked mitochondrial disorder characterised by sensorineural hearing loss, dystonia and optic atrophy. This comprehensive analysis covers all coding exons and flanking intronic regions, ensuring precise diagnosis and family planning guidance for UAE patients.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Methodology | NGS with Sanger confirmation for all detected variants | Conventional Sanger sequencing of selected exons only |
| Coverage | Full TIMM8A gene – coding exons, splice sites, deep intronic hotspots | Limited to predetermined exons; may miss deep intronic or regulatory mutations |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
| Diagnostic Yield | >99.9% analytical sensitivity & specificity | ~95% for known point mutations; structural variants often missed |
Physician Insight & Safety Protocols
“As the supervising Consultant Medical Genetics (DHA License 9294403), I recommend this test for clinically suspected cases. A negative result does not exclude the diagnosis if clinical suspicion remains high, and a positive result requires multidisciplinary management. Every patient deserves compassionate counselling before and after testing.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics
Advisory & Consent Framework
Informed Consent & Clinical Indications
Testing is performed under the UAE Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and consent. A detailed genetic counselling session is required prior to sample collection.
Exclusion Criteria & Emergency Red Flags
Contraindications
- Individuals unable to provide informed consent without a legally authorised guardian (minors require parental consent and mandatory genetic counselling).
- Patient exhibits acute neurological emergency: sudden vision loss, dystonic storm, or new‑onset seizures — seek emergency care immediately; do not delay for genetic testing.
- Severe anaemia or contraindication to venipuncture; alternative sample collection (FTA card) must be arranged.
Patient FAQ & Clinical Guidance
1. What is the TIMM8A gene test for?
This genetic test identifies disease‑causing mutations in the TIMM8A gene linked to deafness‑dystonia‑optic neuropathy syndrome. It helps confirm a clinical diagnosis, guide treatment, and inform family members about inheritance risk.
2. How is the sample collected and what is the turnaround time?
A hospital‑grade phlebotomist visits your home between 8 AM and 11 PM to collect a blood sample using cold‑chain transport, or you may provide a DNA‑stabilised FTA card. Results are available within 3 to 4 weeks, with telephonic post‑test counselling included.
3. Is this test covered by insurance in the UAE?
Many UAE insurers honour direct billing for genetic testing when medically indicated; our team verifies your coverage via WhatsApp (+971 54 548 8731) before the test. A valid physician referral is typically required.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
Laboratory operations adhere to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Data security and patient privacy are governed by UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | TIMM8A Gene Jensen Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (or DNA‑stabilised FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger confirmation |
| ICD‑10‑CM Code | G31.8, H90.5, Z84.3 |
| LOINC Code | 81247-1 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians